H-M Ryoo: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

RUNX2 mutations in cleidocranial dysplasia patients

H-M Ryoo, H-Y Kang, S-K Lee, K-E Lee, J-W Kim

Journal:

Year:

2010

Language:

english

File:

PDF, 763 KB

english, 2010

2

Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum

Yoon, D H, Ryu, M-H, Park, Y S, Lee, H J, Lee, C, Ryoo, B-Y, Lee, J-L, Chang, H-M, Kim, T W, Kang, Y-K

Journal:

British Journal of Cancer

Year:

2012

Language:

english

File:

PDF, 395 KB

english, 2012

3

Oral rivaroxaban versus subcutaneous low molecular weight heparin treatment for venous thromboembolism in patients with upper gastrointestinal, hepatobiliary and pancreatic cancer

Seo, S., Ryu, M-H., Kang, Y-K., Kim, K-P., Chang, H-M., Ryoo, B-Y., Kim, S.B., Lee, J-L., Park, S.R.

Journal:

Annals of Oncology

Year:

2016

Language:

english

File:

PDF, 35 KB

english, 2016

4

717PPrognostic implication of inflammation-based prognostic scores in patients with intrahepatic cholangiocarcinoma (iCCA) treated with first-line Gemcitabine plus Cisplatin (GEMCIS)

Cho, H., Yoo, C., Kim, K-P., Chang, H-M., Ryoo, B-Y.

Journal:

Annals of Oncology

Year:

2017

Language:

english

File:

PDF, 47 KB

english, 2017

5

598PPD-L1 expression in resected colorectal adenocarcinomas is associated with micrometastais

Park, K.U., Hwang, I., Ryoo, H-M., Heo, M.H.

Journal:

Annals of Oncology

Year:

2017

Language:

english

File:

PDF, 49 KB

english, 2017

6

Efficacy and safety of targeted agents for treatment of gastroenteropancreatic (GEP) neuroendocrine tumor (NET)

Chae, H., Yoo, C., Kim, K-P., Chang, H-M., Kim, T.W., Hong, Y.S., Hong, S-M., Kim, S.C., Ryoo, B-Y.

Journal:

Annals of Oncology

Year:

2016

Language:

english

File:

PDF, 62 KB

english, 2016

7

718PPhase 2 study of triplet chemotherapy with oxaliplatin, irinotecan and S-1 (OIS) as first-line treatment in patients with advanced biliary tract cancer (BTC)

Yoo, C., Han, B., Kim, K-P., Kim, H.S., Kim, J.H., Chang, H-M., Ryoo, B-Y., Zang, D.Y.

Journal:

Annals of Oncology

Year:

2017

Language:

english

File:

PDF, 91 KB

english, 2017

8

261P Efficacy of chemotherapy in patients with unresectable or metastatic pancreatic acinar cell carcinoma: Potentially improved efficacy with oxaliplatin-containing regimen

Cheon, J., Yoo, C., Kim, B., Kim, K-P., Lee, J-L., Kim, T.W., Ryoo, B-Y., Chang, H-M.

Journal:

Annals of Oncology

Year:

2016

File:

PDF, 67 KB

2016

9

719PPrognostic impact of hepatitis B virus (HBV) infection in advanced intrahepatic cholangiocarcinoma (iCCA) patients (pts) treated with first-line gemcitabine plus cisplatin (GEMCIS)

Kim, E.J., Cho, H., Yoo, C., Kim, K-P., Chang, H-M., Ryoo, B-Y.

Journal:

Annals of Oncology

Year:

2017

File:

PDF, 77 KB

2017

10

729PPrognostic implication of inflammation-based scores in patients with metastatic pancreatic cancer (mPC) treated with first-line nab-paclitaxel plus gemcitabine (AG)

Hwang, I, Kang, J, Yoo, C, Jeong, J H, Kim, K-P, Chang, H-M, Ryoo, B-Y

Journal:

Annals of Oncology

Year:

2018

File:

PDF, 91 KB

2018

11

725PEfficacy and safety of nab-paclitaxel plus gemcitabine (AG) vs. FOLFIRINOX (FFX) as first line chemotherapy for metastatic pancreatic cancer (mPC): Retrospective analysis

Lee, K, Hwang, I, Kang, J, Yoo, C, Kim, K-P, Jeong, J H, Chang, H-M, Ryoo, B-Y

Journal:

Annals of Oncology

Year:

2018

File:

PDF, 77 KB

2018

12

193PPrognostic implication of inflammation-based scores in patients with metastatic pancreatic cancer (mPC) treated with first-line nab-paclitaxel plus gemcitabine (AG)

Ip, H N N, Hwang, I, Kang, J, Kim, K-P, Jeong, J H, Chang, H-M, Ryoo, B-Y, Yoo, C

Journal:

Annals of Oncology

Year:

2018

File:

PDF, 78 KB

2018

13

689PPhase II trial of preoperative modified FOLFIRINOX (mFOLFIRINOX) followed by postoperative gemcitabine (GEM) in patients (pts) with borderline resectable (BR) and locally advanced (LA) pancreatic ductal adenocarcinoma (PDAC)

Jeong, J H, Yoo, C, Kim, K-P, Chang, H-M, Ryoo, B-Y

Journal:

Annals of Oncology

Year:

2019

File:

PDF, 78 KB

2019